State Drug Alert: CDSCO Flags 78 NSQ, Spurious, Misbranded Drug Samples in April Quality Checks
Written By : Susmita Roy
Published On 2026-05-25 06:15 GMT | Update On 2026-05-25 06:15 GMT
New Delhi: Reflecting continuing concerns over medicine quality and regulatory compliance in India's pharmaceutical market, the Central Drugs Standard Control Organisation (CDSCO) has flagged 78 drug, medical device, and cosmetic samples as Not of Standard Quality (NSQ), spurious, or misbranded in its April 2026 drug safety alert, based on reports submitted by State Drug Testing Laboratories across the country.
The latest alert includes a wide range of pharmaceutical products such as tablets, capsules, syrups, injections, oral suspensions, lotions, powders, and surgical products across multiple therapeutic categories including antibiotics, antihypertensives, antidiabetics, gastrointestinal medicines, respiratory formulations, painkillers, dermatology products, nutritional supplements, and steroid preparations.
Several widely used medicines failed critical quality parameters including dissolution, assay, sterility, microbial contamination, disintegration, identification, and labelling compliance. In some cases, drugs were reportedly found to contain “Nil” active pharmaceutical ingredient content, raising serious concerns over patient safety and therapeutic efficacy.
Among the prominently flagged products were Esomeprazole Tablets IP manufactured by Zoic Biotech Pvt. Ltd. and Adwin Pharma, which failed dissolution tests; Telmisartan Tablets manufactured by Helax Health Care Pvt. Ltd., Alembic Pharmaceuticals Ltd., and Bennet Pharmaceuticals Limited, which failed assay and dissolution standards; and Metoprolol Succinate prolonged-release tablets manufactured by Helax Health Care Pvt. Ltd., which reportedly failed IP standards and also showed discrepancies in product labelling.
Several antibiotic formulations also came under scrutiny. Cefixime Tablets manufactured by Alkem Health Science and Cefpodoxime Tablets manufactured by Aristo Pharmaceuticals and VADSP Pharmaceuticals were declared spurious or failed identification and assay tests. Amoxycillin and Potassium Clavulanate formulations manufactured by multiple companies, including Sun Pharmaceuticals, Alkem Health Science, Finecure Pharmaceuticals, and VADSP Pharmaceuticals, reportedly failed dissolution or assay parameters, while some batches allegedly did not contain the required amount of clavulanic acid.
A number of gastrointestinal medicines were also flagged. Pantoprazole and Rabeprazole formulations manufactured by Aristo Pharmaceuticals, Oaksun Lifesciences, Keylink Global Exim, and Inventia Healthcare reportedly failed identification, dissolution, or assay tests. One batch of Pantoprazole & Domperidone Capsules manufactured by Aristo Pharmaceuticals was declared spurious after reportedly failing identification and assay requirements.
The alert additionally identified several products as spurious or misbranded under the provisions of the Drugs and Cosmetics Act, 1940. R Zara-DSR Capsules manufactured by Samay Pharma India Pvt. Ltd. were declared spurious after assay contents of Rabeprazole Sodium and Domperidone were reportedly found “Nil”. Similarly, multiple products were flagged for incorrect or incomplete labelling declarations.
Apart from pharmaceutical formulations, the alert also covered cosmetic and surgical products. Activated Teeth Whitening Powder with Charcoal manufactured by Dentiglow and ALPC Wellness Rosemary Water for Hair reportedly failed microbial count standards. Mehandi cones manufactured by Pushp Henna Pvt. Ltd. and surgical absorbent gauze and rolled bandages manufactured by firms in Tamil Nadu and Haryana also failed quality parameters related to microbial load, dimensions, and labelling compliance.
Under the Drugs and Cosmetics Act, 1940, a product is categorised as “Not of Standard Quality” if it fails to comply with standards prescribed under the Indian Pharmacopoeia (IP) or other regulatory specifications. Such standards are mandatory to ensure the safety, quality, and effectiveness of medicines and healthcare products marketed in the country.
| S.No | Name of Product | Batch No | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reporting Source | Reporting by Lab/State | Reporting Month & Year |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Esomeprazole Tablets IP | ZTF-037A | Jun-2025 | May-2027 | Zoic Biotech Pvt .Ltd, Plot no.C-15, Focal Point , Ind.Area, Chanalon, Mohali , Punjab-140103 | The sample fails the test 'Dissolution' as per IP | State Lab | DTL Konni | APR-2026 |
| 2 | Telmisartan Tab I.P 40 mg | GT-2508 | Mar-2025 | Feb-2027 | Helax Health Care Pvt. Ltd. Khasra No 410, Vill- Karondi, Dist- Haridwar | SAMPLE DOES NOT CONFIRM TO IP. | State Lab | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15 | APR-2026 |
| 3 | Metjeel 25 XL ( Metoprolol Succinate Prolonged Released Tablet I.P ) | TN - 5974 | Sep-2025 | Aug-2027 | Helax Health Care Pvt. Ltd. Khasra No 410, Vill- Karondi, Dist- Haridwar | 1) SAMPLE DOES NOT CONFIRM TO IP. 2) The sample strip shows the product name " METJEEL 25XL" where the inspection memo shows it "Meetjeel 25XL" | State Lab | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15 | APR-2026 |
| 4 | Erythromycin Stearate Tablets IP | ATG5K933 | Nov-2025 | Oct-2027 | Anrose Pharma, 147, Mauza-Sansiwala, Post-Barotiwala, Tehsil-Kasauli, Distt. Solan (H.P) | Description | State lab | DTL, Puducherry | APR-2026 |
| 5 | Ibuprofen And Paracetamol Tablets IP | ISW24176 | Aug-2024 | Jul-2027 | IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63, Vill. Juddi Kalan, Baddi-173 205, Distt. Solan (H.P) | Disintegration | State lab | DTL, Puducherry | APR-2026 |
| 6 | Loperamide Hydrochloride Tablets IP 2mg | GTE1588 | May-2025 | Apr-2027 | Gidsha Pharmaceuticals, Plot No. 611 612 , Mega GIDC, Kharedi, Dahod, 389151, Gujarat | Misbranded-Incorrect Labelling | State lab | DTL, Puducherry | APR-2026 |
| 7 | Paracetamol Tablets IP 650 mg | CAAL25054 | Dec-2025 | Nov-2028 | Curetech Formulations (P) Ltd., Vill.Juddi,kalan,Baddi-173 205 Distt Solan (HP) | Dissolution | State lab | DTL, Puducherry | APR-2026 |
| 8 | Ibuprofen and Paracetamol Tablets IP | TB251005 | Dec-2025 | Nov-2027 | Agron Remedies Pvt. Ltd. Sarverkhera, Moradabad Road, Kashipur-244713 (Uttarakhand) | The sample fails in the Test for Description | State lab | MDTL Kathua | APR-2026 |
| 9 | Diabit-GM | T25F640A | Jun-2025 | May-2027 | Bajaj Formulations Khasra No. 161, Village- Lakeshwary, Bhagwanpur, Roorkee, Distt. Haridwar (U.K) | The sample fails in the Test for Description | State lab | MDTL Kathua | APR-2026 |
| 10 | R Zara-DSR Capsules | SC-05856 | Oct-2025 | Sep-2027 | Samay Pharma India Pvt. Ltd. Plot No. 34-35, Industrial Area, Trilokpur Road, Kala Amb, District Sirmour, Himachal Pradesh-173030 | SPURIOUS 1.The sample fails in the test for Identification & also the Assay contents of Rabeprazole Sodium IP & Domperidone IP are found NIL. 2.The sample is also found Misbranded as Sunset Yellow in the label needs to be mentioned Sunset Yellow FCF. | State lab | MDTL Kathua | APR-2026 |
| 11 | Albendazole Tablets IP 400mg | 296725043 | Apr-2025 | Mar-2027 | Ravenbhel Healthcare Pvt.Ltd. 16-17,EPIP,SIDCO Kartholi,Baroi Brahmana,Jammu-181133 | The sample does not conform to IP 2022 requirements w.r.t Dissolution Test | State lab | DTL,Dalgate Srinagar kashmir. | APR-2026 |
| 12 | Esomeprazole Tablets IP | AYT070385 | Jul-2025 | Jun-2027 | Adwin Pharma , Vill Rampur Jattan, Trilokpur Road kala Amb Tehsil Nahan Distt .Sirmour (HP) 173030. | The sample does not conform to IP 2022 requirements w.r.t Dissolution Test | State lab | DTL,Dalgate Srinagar kashmir. | APR-2026 |
| 13 | Dexamethasone sodium Phosphate Injection IP | DIH-227/10 | Oct-2025 | Sep-2027 | Indo Gulf Pharmaceuticals 5.4 Km,Meerut Road,Muzaffarnagar-251003(UP) | The sample does not conform to IP 2022 requirements w.r.t Sterility Test | State lab | DTL,Dalgate Srinagar kashmir. | APR-2026 |
| 14 | Ofloxacin 100mg, Ornidazole 2500mg & Loperamide 7.5mg Bolus IP | DF-1677 | Sep-2025 | Aug-2027 | DUTCH FORMULATIONS 32, Industrial Area Village Johron, Kala-Amb, Distt Sirmour H.P-173030 | Assay of Ofloxacin, Ornidazole & Loperamide | State lab | CFDL Jammu | APR-2026 |
| 15 | Pantoprazole & Domperidone Capsules IP | SPJ241197 | Sep-2024 | Aug-2026 | Aristo Pharmaceuticals Private Ltd., Vill Makhnumajra, P.O.- Bhud, Baddi, Dist. Solan (H.P.) -173205 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay Spurious | State Lab | SDTL, Assam | APR-2026 |
| 16 | Cefixime Tablets IP 200 mg | 25460922 | May-2025 | Apr-2027 | Alkem Health Science, A Unit of Alkem Laboratories Limited Unit-2, Samardung, Karek Block, P.O.- Namthang, Dist. Namchi, Sikkim-737137 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay Spurious | State Lab | SDTL, Assam | APR-2026 |
| 17 | Ofloxacin & Ornidazole Tablets IP | E50058 | Jan-2025 | Dec-2028 | Medley Pharmaceuticals Ltd., Lane No- 3, Phase-1, SIDCO Industrial Complex, Bari Brahmana, Jammu-181133 | The sample does not conform to I.P. w.r.to the tests for Dissolution And Assay | State Lab | SDTL, Assam | APR-2026 |
| 18 | Cefpodoxime Tablets IP 200 Mg | BPA250167 | Jan-2025 | Dec-2026 | Aristo Pharmaceuticals Private Ltd., Vill Makhnumajra, P.O.- Bhud, Baddi, Dist. Solan (H.P.) -173205 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay Spurious | State Lab | SDTL, Assam | APR-2026 |
| 19 | Telmisartan & Amlodipine Tablets IP | BPF251519 | Jun-2025 | May-2027 | Aristo Pharmaceuticals Private Ltd., Vill Makhnumajra, P.O.- Bhud, Baddi, Dist. Solan (H.P.) -173205 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay Spurious | State Lab | SDTL, Assam | APR-2026 |
| 20 | Telmisartan Tablets IP 40 mg | 2513000079 | Aug-2025 | Aug-2027 | Alembic Pharmaceuticals Ltd., Samardung Basti, Karek Block, Namthang Ilaka, Namchi, Sikkim-737126 | The sample does not conform to I.P. w.r.to the tests for Dissolution & Assay | State Lab | SDTL, Assam | APR-2026 |
| 21 | Calcium & Vitamin D3 Tablets | 24443315 | Sep-2024 | Aug-2026 | Alkem Health Science, A Unit of Alkem Laboratories Limited Unit-2, Samardung, Karek Block, P.O.- Namthang, Dist. Namchi, Sikkim-737137 | The sample does not conform to I.P. w.r.to the tests for Dissolution & Assay | State Lab | SDTL, Assam | APR-2026 |
| 22 | L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid Tablets | B95Y032 | Mar-2025 | Feb-2027 | M/s: Mandkind Pharma Ltd., Doring Block, Bermiok Elaka, Dist. Namchi, Sikkim-737126 | The sample does not conform to I.P. w.r.to the tests for Identification ,Assay and Dissolution Spurious | State Lab | SDTL, Assam | APR-2026 |
| 23 | Paracetamol Tablets IP 500mg | IPCL25031 | May-2025 | Apr-2028 | Pinnacle Klife Science Private Limited, At Khasra, No.63, Vill. Juddi Kalan. Baddi-173205, Distt. Solan(H.P.) | The sample does not conform to I.P. w.r.to the tests for Dissolution. | State Lab | SDTL, Assam | APR-2026 |
| 24 | Telmisartan Tablets IP 40 Mg | BPLT-25104 | May-2025 | Apr-2027 | Bennet Pharmaceuticals Limited, Vill.ChanalMajra, NR. Manpura, Bdadi, Tal. Nalagarh, Distt. Solan(H.P.) 173205 | The sample does not conform to I.P. w.r.to the tests for Dissolution. | State Lab | SDTL, Assam | APR-2026 |
| 25 | Paracetamol, Phenyephrine hydrochloride, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension | 241175 | Nov-2024 | Oct-2026 | True Life Pharma Pvt. Ltd., 18,19, Shyam Estate, Santej- Khatraj Raod,Santej, Ta.: Kalol, Dist.: Gandhinagar-382721. | Phenyephrine hydrochloride content | State Lab | FDL, Vadodara | APR-2026 |
| 26 | Levosalbutamol, Ambroxol & Guaiphenesin Syrup | L25071 | Nov-2024 | Oct-2026 | Tuttsan Pharma Pvt. Ltd., Plot No. 10, Block No. 58, At & Post :Khatraj, Ta.: Kalol, Dist. : Gandhinagar. | Guaiphenesin Content | State Lab | FDL, Vadodara | APR-2026 |
| 27 | Dextromethorphan hydrobromide, phenylephrine hydrochloride & Chlorpheniramine Maleate Syrup | L 24371 | Nov-2024 | Oct-2026 | KNM Pharma Pvt. Ltd., 13, Mahagujarat Industrial Estate, opp. Nova Petrochemicals Limnited., Moraiya, Ta.: Sanand, Dist.: Ahmedabad, Gujarat | Microbial Contamination (Total Aerobic Viable Count) | State Lab | FDL, Vadodara | APR-2026 |
| 28 | Dextromethorphan hydrobromide, phenylephrine hydrochloride & Chlorpheniramine Maleate Syrup | L 24326 | Nov-2024 | Oct-2026 | KNM Pharma Pvt. Ltd., 13, Mahagujarat Industrial Estate, opp. Nova Petrochemicals Limnited., Moraiya, Ta.: Sanand, Dist.: Ahmedabad, Gujarat | Microbial Contamination (Total Aerobic Viable Count) | State Lab | FDL, Vadodara | APR-2026 |
| 29 | Nifedipine Sustained Released Tablet IP | NR019 | Nov-2024 | Oct-2026 | Nabros Pharma Pvt. Ltd., NH No. 8, Kheda-387411 | Dissolution | State Lab | FDL, Vadodara | APR-2026 |
| 30 | Enteric Coated Rabeprazole Sodium 20 mg & Domperidone Sustained Release 30 mg Capsules | 404F004 | Nov-2024 | Oct-2026 | Inventia Healthcare Limited., F1-F1/1, Additional Ambernath, MIDC, Ambernath (East), Dist.: Thane-421506. | Rabeprazole Sodium Content | State Lab | FDL, Vadodara | APR-2026 |
| 31 | Cefuroxime Axetil Tablets I.P. | SSTG25503 | Jan-2026 | Dec-2027 | Shri Sai Balaji Pharmatech Pvt Ltd. 20 Ext HPSIDC Ind. Area Baddi H.P. | Assay | State Lab | DTL Baddi Distt. Solan HP | APR-2026 |
| 32 | Sodium Bicarbonate Enteric Coated Tablets 500 mg | STG-250674 | Jan-2025 | Jan-2027 | Supermax Drugs & Pharmaceuticals Pvt. Ltd.(Unit-II) Khasra No.322, Nanheda, Anantpur, Bhagwanpur, Roorkee-247668 Distt. Haridwar, Uttarakhand | The sample does not confirm to claim as per Patent & Proprietory in respect to the Disintegration Test. | State Lab | DTL Baddi | APR-2026 |
| 33 | Calamine Lotion | 021 | Dec-2024 | Nov-2026 | Medivin (India) Pharma Lab,#51/1,Ramaiahana Palya,Thagachaguppe, Kumbalagodu Post,Bengaluru-560074 | Assay for Calamine (Zinc Oxide) and Liquid Paraffin | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 34 | Ketoconazole Tablets IP 200 mg | AD00112001 | Jan-2025 | Dec-2026 | Admed Pharma Pvt. Ltd., Plot No.87, HPSIDC, Industrial Area, Baddi, Distt. Solan, HP-173205 | Description | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 35 | Ramipril Tablets IP 2.5 mg | BPRA25002 | Apr-2025 | Mar-2027 | Ravian Life Sciences Pvt. Ltd., Plot No.34, Sector-8A,IIE, SIDCUL, Haridwar-249403 (Uttarakhand) | Test for Dissolution and Assay for Ramipril | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 36 | Loperamide Hydrochloride Capsules I.P | C-2127 | Dec-2024 | Nov-2026 | Supercure Biotech Pvt. Ltd., (An ISO 9001:2015 Certified Company) Plot No-99/4/1, Friends Colony, G.T road Kundli, Haryana, India | Dissolution Test | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 37 | Montelukast Sodium and Levocetirizine Dihydrochloride Syrup | SP25990 | Oct-2025 | Sep-2027 | Seejar Pharmaceuticalls, Plot No.5, Survey No.198, Paiki-1/Paiki-2/Paiki-1, B/H CCL Factory, NR. Gokuldham Godown, Budasan, TA. Kadi, Dist. Mehsana-382715 | Assay for Montelukast | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 38 | Calcium and Vitamin D3 Tablets IP | HCL5154 | Apr-2025 | Mar-2027 | Hanuchem Laboratories, Plot No.15-16-17, Sector-5, Industrial Area-Parwanoo, Distt, Solan-173220 (H.P) | Assay for Vitamin D3 | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 39 | Cefixime & Potassium Clavulanate Tablets | MYRTAB-971 | Mar-2025 | Oct-2026 | Mayer Lab, Chambaghat, Adjacent to Railway Crossing, District Solan (H.P)-173213 | Assay for Clavulanic acid | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 40 | Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP (5 mg/10 mg) | 310225017 | May-2025 | Apr-2027 | Ravenbhel Healthcare Pvt. Ltd., 16-17, EPIP, SIDCO, Kartholi Bari Brahmana, Jammu-181133 | Description | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 41 | Sodium Chloride (0.9% w/v) & Dextrose (5%w/v) Injection IP | PT25DNS2148C | Nov-2025 | Oct-2028 | Promea Therapeutics Private Limited, Plot No. M4, Medical Device Park, Sultanpur (V). Ameenpur (M), Sangareddy (Dist), Telangana-502319 | Test for Sterility | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 42 | Cetirizine Hydrochloride Tablets I.P. 10mg | LPT2425300 | Feb-2025 | Jan-2027 | Lannett Pharmaceuticals Pvt. Ltd., Plot No. D-8C & D-8D, Sigaddi Geowth Centre, SIDCUL Industrial Area, Kotdwar-246149 (UK) | Description | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 43 | Flunixin Meglumine Injection 50mg/ml | AFM-02 | Oct-2025 | Sep-2027 | Agron Remedies Pvt. Ltd. Sarverkhera, Moradabad Road, Kashipur-244713 (Uttarakhand) | Description | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 44 | Oxetacaine, Dried Aluminium Hydroxide gel & Magnesium Hydroxide oral Suspension | SP25411 | May-2025 | Apr-2027 | Seejar Pharmaceuticals, Plot No.5, Survey No. 198, Paiki-1/Paiki-2/Paiki-1,B/H CCL Fctory, NR. Gokuldham Godown, Budasan, TA. KADI Dist. Mehsana-382715 | Assay for Oxetacaine, Dried Aluminium Hydroxide gel & Magnesium Hydroxide | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 45 | Aceclofenac, Paracetamol and Serratiopeptidase Tablets | C24T140E | Jan-2025 | Dec-2026 | Cartel Laboratories, An ISO 9001: 2015 & GMP Certified Company Plot No.10/A & 11/A, Chengicherla, Medchal-Malkajgiri Dist. Hyderabad-92 | Assay for Serratiopeptidase | State Lab | DTL, Bengaluru, Karnataka | APR-2026 |
| 46 | Aspirin Gastro-Resistant Tablets IP 75mg | ANET1243 | May-2024 | Apr-2026 | Unicure India Ltd, C-21,22&23, Sector-3, Noida- 201 301, Distt.Gautam Budh Nagar (UP) | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IP | State Lab | DTL Thiruvananthapuram | APR-2026 |
| 47 | Glimepiride Tablets IP | AMT-2153 | Sep-2025 | Aug-2027 | Avalon Medicines Pvt. Ltd., Plot No.1271, Phase I, Sector 38, HSIIDC, RAI, Sonepat-131029 (HR) | The sample fails the test 'Dissolution' as per IP | State Lab | DTL Thiruvananthapuram | APR-2026 |
| 48 | Methyl Prednisolone Tablets IP 4mg | B2508249B | Aug-2025 | Jul-2027 | Bymaa Laboratories Private Limited, A-19,20,21&22, Electronic Park, PIPDIC Industrial Estate, Thirubhuvanai, Puducherry- 605107 | The sample fails the test 'Dissolution' as per IP | State Lab | DTL Thiruvananthapuram | APR-2026 |
| 49 | Amoxycillin & Potassium Clavulanate Tablets IP | ABT25223 | Aug-2025 | Jan-2027 | Plot No. 20, Ext. HPSIDC Ind Area, Baddi, Dist. Solan HP-173205 | The content of Amoxycillin in the sample is less(i.e.49.79% of stated amount) and the content of clavulanic acid in the sample is less (i.e.6.56% of the stated amount) than IP limit. (IP Limit-Not less than 90% and Not more than 120% of stated amount) The content of Clavulanic Acid in the sample is less (i.e 29.38% of stated amount ) than the IP limit (IP limit not less than 80% of sated amount) 2. The sample does not comply with IP requirements for the Dissolution test of Amoxicillin and Clavulanic Acid | State Lab | FDAL, Maharashtra | APR-2026 |
| 50 | Rabeprazole Sodium Tablets | T24.398 | Aug-2024 | Jul-2026 | Oaksun Lifesciences, Plot No. 36,37,38,46&47, Chengicherla (V) Medipally (M), Medchal - Malkajigiri (Dist.) T.S.-500092 | Dissolution test under acid & Buffer stage | State Lab | SDT&RL, Bhubaneswar | APR-2026 |
| 51 | Pantoprazole Sodium Tablets 40 mg | T24.240 | May-2024 | Apr-2026 | Oaksun Lifesciences, Plot No. 36,37,38,46&47, Chengicherla (V) Medipally (M), Medchal - Malkajigiri (Dist.) T.S.-500092 | Dissolution (buffer stage) | State Lab | SDT&RL, Bhubaneswar | APR-2026 |
| 52 | Cyproheptadine Hydrochloride Syrup I.P. | SR-086 | Dec-2024 | Nov-2026 | Sresan Pharmaceutical Manufacturer 787, Bangalore Highways, Sunguvarchatiram, Kancheepuram Dist-602106 | Content of Cyproheptadine HCI | State Lab | SDT&RL, Bhubaneswar | APR-2026 |
| 53 | Ramipril Tablets I.P. 1.25mg | MLS-24943 | Oct-2025 | Sep-2026 | Nexkem Pharmaceuticals Pvt. Ltd., Khasra No.-69-70, Khatakheri, Bhagwanpur, Roorke-247667, Haridwar (U.K.) | Content of Ramipril & Dissolution test | State Lab | SDT&RL, Bhubaneswar | APR-2026 |
| 54 | Ferrous Ascorbate and Folic Acid Tablet | NAC25006 | Nov-2025 | Oct-2027 | Nuvista Pharmaceuticals Pvt.Ltd, Plot No. 48, Phase-II, IDA, Mallapur, Medchal, Malkajgiri, Hyderabad - 76 Telangana. | 1. Assay for Elemental Iron Does not complies as per IP 2022. 2. In the compostion the label should be mentioned as Ferrous Ascorbate and Folic Acid IP. But the label is mentioned as only Ferrous Ascorbate and Folic Acid. The letters IP is not mentioned on the strip. 3. In the compostion it should be mentioned as Ferrous Ascrobate equivalent to Elemental Iron, but it is labelled as only Ferrous Ascorbate 100 mg. | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 55 | Albendazole Tablets IP | PGT24427 | Jul-2024 | Jun-2027 | Affy Parenterals, Vill. Gullerwala, P.O. Baddi, Distt. Solan-173205 (HP) | The sample does not conform to the IP with respect to Dissolution. | State Lab | DTL Jaipur | APR-2026 |
| 56 | Cefpodoxine Proxetil Tablets IP | VT242312 | Dec-2024 | Nov-2026 | VADSP PHARMACEUTICALS, Plot No.: 124, E.P.I.P. Ind. Area Phase-1, Jharmajri, Baddi (H.P.) 174103. | The sample does not conform to the IP as it does not contain Cefpodoxime (Nil) | State Lab | DTL Jaipur | APR-2026 |
| 57 | Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Drops | GLF0712B | Jul-2025 | Jun-2027 | Digital Vision, 176, Mauza Ogli, Nahan Road, Kala-Amb, Distt. Sirmour (H.P.)-173030. Mfd For : M/s Acoowell Pharma Pvt. Ltd., Nagar Suketi Road, Kala Amb, Distt. Sirmour-173030 (H.P.) | The sample does not conform to the claim with respect to Assay. | State Lab | DTL Jaipur | APR-2026 |
| 58 | Methylprednisolone Tablets IP 4mg | T252005 | Jul-2025 | Jun-2027 | United Bioceuticals Pvt. Ltd., Plot No. 33 C, Industrial Park-IV, Begumpur, Haridwar-249402, Uttarakhand. | The sample does not conform to the IP with respect to in Assay & Dissolution of Methylprednisolone. | State Lab | DTL Jaipur | APR-2026 |
| 59 | Dextromethorphan Hbr & Chlorphenramine Maleate Syrup | TLLM-188 | Dec-2024 | Nov-2026 | Taksa Lifesciences Pvt. Ltd., E-47, Industrial Area, Focal Point, Derabassi, Distt. Mohali (PB) Pin Code 140507 | The sample does not conform to the claim with respect to Assay of Chlorpheniramine Maleate. | State Lab | DTL Jaipur | APR-2026 |
| 60 | Cefuroxime Axetil Tablets IP | VT252942 | Mar-2026 | Feb-2028 | VADSP PHARMACEUTICALS, Plot No.: 124, E.P.I.P. Ind. Area Phase-1, Jharmajri, Baddi (H.P.) 174103. | The sample does not conform to the IP with respect to Assay. | State Lab | DTL Jaipur | APR-2026 |
| 61 | Ciprofloxacin Tablets I.P. 500 mg | GT50135 | May-2025 | Apr-2028 | Omega Pharma, Khasra No.-482, Village-Saliyar, Roorkee- 247667, Distt. Haridwar (Uttarakhand) | The sample does not conform to the IP with respect to Assay and Dissolution of Ciprofloxacin Hydrochloride Equivalent to Ciprofloxacin. | State Lab | DTL Jaipur | APR-2026 |
| 62 | Coral Calcium & Vitamin D3 Tablets | MLS-251719 | Feb-2026 | Jan-2028 | Maskon Life Sciences Pvt. Ltd., Kh. No. 69 &70, Khatakheri, Bhagwanpur, Roorkee (U.K.) India | The sample does not conform to the claim with respect to Assay of Vitamin D3 (Nil). | State Lab | DTL Jaipur | APR-2026 |
| 63 | Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets | VT252296 | Dec-2025 | May-2027 | VADSP PHARMACEUTICALS, Plot No.: 124, E.P.I.P. Ind. Area Phase-1, Jharmajri, Baddi (H.P.) 174103. | The sample does not conform to the claim as it does not contain Clavulanic Acid (Nil). | State Lab | DTL Jaipur | APR-2026 |
| 64 | Povidone-Iodine Solution IP (10%) | RSPI25091B | Sep-2025 | Aug-2027 | Rsons Medikits India 5-5-35/275/2, 1st Floor, Shaktipuram, I.E. Kukatpally, Hyderabad - 500072 Telangana. | Assay for available Iodine does not complies as per IP 2022 monograph. | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 65 | Azithromycin Oral Suspension 100 ml | 25243 | Jul-2025 | Jun-2027 | HYT Formulations 1st 2nd & rd Floors Room, 7-17/28, Satyanarayanapuram, Parvathapur, Medipally, Hyderabad - 50009 Telangana. | The sample does not meets the Specification wrt. Assay of Azithromycin as per STP. | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 66 | Rosuvastatin with Fenofibrate Tablets | RDF-2504 | Jun-2025 | Jun-2027 | Life Line Pharma 188/1, Iyyanar Koil Road, Mettupalayam, Puducherry - 605009. Puducherry.605009 | MISBRANDED DRUG In the composition the label should be mentioned as Rosuvastatin and Fenofibrate tablets IP. But the label is mentioned as only Rosuvastatin and Fenofibrate tablets. Hence it is Misbranded drug as per section 17 of Drugs and Cosmetics Act 1940. | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 67 | Pantoprazole Gastro ? Resistant & Domperidone Prolonged ? Release Capsules IP | KC25G002 | Jul-2025 | Jun-2027 | Keylink Global Exim Pvt. Ltd., K.H. No. 111/143, Vill. Dhermajra, Tehsil, Nalagarh, Distt. Solan (H.P.) ? 174101. | The sample does not conform to Standard Quality in respect of the tests for Dissolution in Buffer stage performed. | State Lab | SDTL, Tripura | APR-2026 |
| 68 | Amoxycillin and Potassium Clavulanate Tablets IP | BYC0043 | Aug-2025 | Jan-2027 | Sun Pharmaceuticals Ind. Ltd., Acme Plaza, Andheri ? Kurla Road, Andheri (E) , Mumbai ? 400059. | The sample does not conform to standard in respect of the test for Dissolution of Amoxycillin performed. | State Lab | SDTL, Tripura | APR-2026 |
| 69 | Amoxycillin and Potassium Clavulanate Tablets IP | 25442306 | Jun-2025 | Nov-2026 | Alkem Health Science, A unit of Alkem Laboratories Limited, Unit-2, Samardung, Karek Block, P.O.: Namthang, Distt. Namchi, Sikkim - 737137. | The sample does not conform to standard quality in respect of the test for ?Dissolution of Amoxycillin and Assay for Clavulanic Acid performed. | State Lab | SDTL, Tripura | APR-2026 |
| 70 | Amoxycillin and Potassium Clavulanate Tablets IP | CF10077 | Mar-2025 | Aug-2026 | Finecure Pharmaceuticals Ltd., Plot No. C14+C15+C16/1, Arvind Megapark, Vasna Chacharwadi, Taluka:Sanand, Ahmedabad. | The sample does not conform to standard in respect of the test for Dissolution of Amoxycillin performed. | State Lab | SDTL, Tripura | APR-2026 |
| 71 | Rolled Bandage, Schedule F (II) | 26 | Apr-2025 | Apr-2028 | Karunamoorthy Surigcals Ayyanapuram, Chatrapatti - 626 102 Tamil Nadu. | The sample does not complies for test parameyters1. Length 2,Width 3. Warp and 4.Weight in Grams/Sq.Met | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 72 | Absorbent Cotton Wool I.P | 2085 | Mar-2025 | Feb-2027 | Jind Surgicals 24-27, HSIIDC Industrial Area, New Hansi Road, Jind-126102, Haryana | The sample is not of standard quality for the reason stated under Description | State Lab | RDTL,Guwahati | APR-2026 |
| 73 | Absorbent Gauze IS 758 | 183 | Aug-2025 | Jul-2028 | Sri Vishnuram Company 759/15, Balasubramaniapuram Street, Post Box NO. 30, Chatrapatti - 626 102. Tamil Nadu. | The sample does not complies for test parameters 1. Threads per dm 2.Length 3. Width and 4.Weight In Gm/Sq.Met. | State Lab | State Lab, DCL, Telangana | APR-2026 |
| 74 | Liquid Paraffin IP 100 ml | 208 | Dec-2025 | May-2028 | Repacked by- Medi Smith Pharma Lab, #20A 1st Phase, KIADB, Mysore Road, Kumbalagodu, Bangalore- 560074 | The sample fails the test Light Absorption as per IP | State Lab | DTL Thiruvananthapuram | APR-2026 |
| 75 | Mehandi Cone | PMC1744 | Dec-2025 | Nov-2026 | PUSHP HENNA PVT. LTD., Regd. Office : Nr. Kushal Krishi Farm, Sojat Road Marg, Sojat City?306104 (Raj.) India | The Sample does not conform to claim as per IS 17318:2020 in respect to the Test of Total viable count. | State Lab | RDTL Chandigarh | APR-2026 |
| 76 | Activated Teeth Whitening Powder with Charcoal | DC5092 | Nov-2024 | Oct-2026 | Dentiglow, Surat-395006 | Total Microbial Count & Total Yeast and Mould Count | State Lab | FDL, Vadodara | APR-2026 |
| 77 | ALPC Wellness Rosemary Water for thick Hair | AR5112 | Nov-2024 | Oct-2026 | ALPC, Surat | Total Microbial Count | State Lab | FDL, Vadodara | APR-2026 |
| 78 | Prem Dulhan Fast Colour Cone (For Fast & Dark Colour) | PD07A | Jul-2025 | Jun-2026 | Prem Green Pvt. Ltd., Khasra No. 678/12, Siryari Road, Vill. Vopari, Tehsil- Marwar Junction, District-Pali (Raj)-306023. | The sample fails to comply in respect of labelling as per cosmetic Act. | State Lab | DTL Bhopal | APR-2026 |
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.